Clamoring to Invest in SpaceX but Can't? Consider Buying Stock in This Competitor That Just Upped Its National Defense Game.

With SpaceX unavailable to public investors, Rocket Lab (RKLB) is presented as an alternative for exposure to the space economy, particularly national defense launch programs; Rocket Lab's Electron program is already reliably launching payloads, and the company is developing the Neutron rocket to compete more directly with SpaceX. Rocket Lab's relationship with the U.S. government and potential contracts, such as those tied to missile defense systems, could be lucrative, but the stock has a high price-to-sales ratio of 28.5 and has never turned a profit, making it a potentially risky investment.

Analysis

Rocket Lab (NASDAQ: RKLB) is presented as a publicly traded alternative for investors seeking exposure to the space economy, particularly given the private status of SpaceX. The company has established a niche with its Electron program, consistently executing launches for commercial and government clients, including national defense contracts like HASTE, by catering to smaller payloads where SpaceX's larger systems are less suitable. This strategy has cultivated a relationship with the U.S. government, positioning Rocket Lab for potential growth from increased defense spending, exemplified by the prospective $175 billion Golden Dome missile defense system and enhanced by the $275 million acquisition of satellite laser operator Geost. Looking forward, Rocket Lab aims to compete more directly with SpaceX through its larger Neutron rocket, currently in testing with commercial launches anticipated next year; success with Neutron could significantly expand its $1 billion-plus backlog, supported by a proposed contract for 2026 and inclusion in the $5.6 billion National Security Space Launch (NSSL) program extending through 2029. However, Rocket Lab's stock carries a high price-to-sales (P/S) ratio of 28.5, comparable to SpaceX's estimated P/S of 27 and significantly above the S&P 500 average of 3. This valuation, coupled with the company's lack of profitability to date, categorizes it as a high-risk investment, a sentiment underscored by its absence from a recent 'top 10 best stocks' list by The Motley Fool Stock Advisor.

Key Decisions for Investors

• Investors should view Rocket Lab as a speculative growth opportunity within the space sector, balancing its significant market potential and established launch capabilities against its current unprofitability and elevated P/S ratio of 28.5.
• Closely monitor milestones related to the Neutron rocket's development, testing, and successful commercial deployment, as this is a primary catalyst for substantial revenue growth and achieving scale.
• Track new contract acquisitions, particularly multi-year government and defense agreements like those under the NSSL program, and growth in the company's $1 billion-plus backlog as key indicators of operational execution and market traction.